Cargando…
Patient preference for biologic treatments of psoriasis in Japan
Psoriasis is a chronic autoimmune disease affecting skin which may also manifest in nails and joints. Several biologic treatments have been approved in Japan for psoriasis. Each biologic has a different profile for efficacy and safety, including different dosing regimens and co‐payment consideration...
Autores principales: | Tada, Yayoi, Ishii, Kanako, Kimura, Junko, Hanada, Keigo, Kawaguchi, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594072/ https://www.ncbi.nlm.nih.gov/pubmed/30985030 http://dx.doi.org/10.1111/1346-8138.14870 |
Ejemplares similares
-
Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting
por: Lang, Yitian, et al.
Publicado: (2022) -
Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review
por: Kamata, Masahiro, et al.
Publicado: (2020) -
Treatment patterns, healthcare resource utilization, and costs in patients with moderate‐to‐severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study
por: Tada, Yayoi, et al.
Publicado: (2022) -
Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis
por: Kamata, Masahiro, et al.
Publicado: (2022) -
Crosstalk: keratinocytes and immune cells in psoriasis
por: Kamata, Masahiro, et al.
Publicado: (2023)